Nautilus expects up to $6 million from ARPA-H-funded SEEDS project
NAUT•Nautilus Biotechnology expects to receive up to $6 million over four years through the ARPA-H-funded SEEDS research consortium, which was awarded up to $51.7 million.
1. Consortium research project
Nautilus Biotechnology expects up to $6 million over four years through the SEEDS research consortium, awarded up to $51.7 million and co-led by Buck Institute for Research on Aging and Georgetown University. Its Voyager Platform will measure protein variants linked to Alzheimer's disease and Ewing sarcoma to support diagnostic and therapeutic development.
